Navigation Links
Surveyed Psychiatrists and PCPs Expect to Increase Their First-Line Use of SNRIs Over the Next Two Years for the Treatment of Generalized Anxiety Disorder
Date:6/2/2009

r of side effects.

Patient-flow analysis for GAD shows that Effexor XR is used more frequently than Eli Lilly's Cymbalta following the failure of SSRIs in early lines of treatment. Patient-flow models of Cymbalta, Effexor XR and other branded agents are critical for forecasting patient-flow to generate more accurate estimates of the potential pool of customers for a given brand in this highly genericized market.

About Treatment Algorithm Insight Series

Decision Resources combines in-depth primary research with the most extensive claims-based longitudinal patient-level data from IMS Lifelink: Health Plans Claims database to provide exceptional insight into physicians' prescribing trends and the factors that drive therapy product choice, from diagnosis through multiple courses of treatment, for a specific disease.

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

    Gisselle Morales                        
'/>"/>
SOURCE  Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 

Related medicine news :

1. World Vision Index of Concern: Half of Americans Surveyed Said They Would Be Willing to Pay More Taxes to Combat AIDS
2. Eighty-Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche/Chugais Actemra for Rheumatoid Arthritis
3. Surveyed Neurologists in Both the U.S. and Europe Would Welcome an Antiepileptic Drug That is Administered Once-Daily
4. Half of Full-Time Employees Surveyed Dont Understand Health Insurance Coverage for Cancer-Related Medical Expenses
5. Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohns Disease
6. Less Than Two-Thirds of Surveyed Pharmacy Directors Expect to Reimburse Both Onglyza and Alogliptin Once They are Available for the Treatment of Type 2 Diabetes
7. As a Result of the Jupiter Trial, 65 Percent of Surveyed MCO Pharmacy Directors Will Reimburse Crestor for Patients with Elevated hsCRP
8. Surveyed Oncologists Indicate that Avastin has Advantages over Temodar/Temodal in Increasing Overall Survival of High-Grade Glioma
9. Surveyed Experts Indicate That Xarelto Has Advantages Over Lovenox in the Treatment of Venous Thromboembolism in Medically Ill Patients
10. Surveyed Experts Indicate that Biogen Idecs Adentri Has Advantages Over Nitroglycerin in the Treatment of Acute Heart Failure
11. As a Result of the FDA Investigation Into TNF-Alpha Inhibitors, 30 Percent of Surveyed Rheumatologists Have Altered Their Prescription Patterns for Juvenile Idiopathic Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... ( http://www.sermo.com ), the world,s largest online community ... new Sermo Vitals Report titled " Diabetes: MD ... physician dialog about diabetes over a one-year period ... of topics, including the therapies physicians discuss most ... on issues related to diabetes. ,, Leveraging ...
(Date:12/16/2009)... access to patient information could improve care, but ... 16 (HealthDay News) -- U.S. physicians support the ... exist about privacy problems, two new studies show. ... practice and specialist doctors in Massachusetts found that ... would improve patient quality of care, 70 percent ...
(Date:12/16/2009)... 14, 2009) Unisense FertiliTech A/S has received a further 1.6 million ... of the EmbryoScope™ Embryo Monitoring System in order to meet the ... invested by LD Pensions and Unisense A/S that continue to own ... ... Denmark (PRWEB) December 16, 2009 -- Unisense FertiliTech A/S has received ...
(Date:12/16/2009)... a bachelor degree, an individual can begin working and become ... ... (Vocus) December 16, 2009 -- According to " Measuring ... by the National Center for Public Policy and Higher Education, ... sectors of the economy.”¹ Since 1982, the national price of ...
(Date:12/16/2009)... Hair Shake in all of the Florida Whole Foods store. ... ... Larry Shapiro, hair transplant and hair loss physician , is pleased ... Hair Whey Protein Shake. Dr. Shapiro developed the all natural growth-hormone ... programs, working out and muscle building., , , , ,The Whole Foods ...
Breaking Medicine News(10 mins):Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 2Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 3Health News:Pros and Cons of Electronic Medical Records Weighed 2Health News:Increased Capital Funding for Unisense FertiliTech A/S Will Help Meet Demand for New Assisted Reproduction Device 2Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 2Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 3Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 4Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 5Health News:Florida Whole Foods Stores to Carry Dr. Lawrence Shapiro's Help Hair Shake 2
... Broad-ranging Report Concludes that Increased Resources Are An Essential ... ... food supply,is at risk, as are the regulatory systems that oversee the ... Board,in a report to be presented today. The subcommittee attributes the,deficiencies to ...
... 4, 2007 In a new evidence-based paper, the ... the United States and 12 other industrialized countries and ... political and social culture of the United States to ... universal health insurance coverage for all Americans. , As ...
... for Quality Long-Term Care Recommendations, WASHINGTON, Dec. ... the National Commission for Quality Long-Term Care,for its ... among policymakers,especially this year,s Presidential candidates. We urge ... the long-term care,challenges our nation faces and to ...
... Corporation,(Nasdaq: HSKA ) today announced it will ... December 6, 2007 at the Grand Hyatt Denver, ... scheduled to begin at 5:05,p.m. Mountain Time., ... Heska Corporation (NASDAQ: HSKA ) sells advanced ...
... Evaluates Best Drugs for 35 Conditions, YONKERS, ... needed between doctors and patients, especially,when it comes ... in the,January issue of Consumer Reports, in which ... initiative about drugs for 35 conditions including,Alzheimer,s disease, ...
... studies show strong link to recreational drugs as well. ... U.S. studies of gay and bisexual men who know ... one-third have recently had unprotected intercourse. , In many ... other HIV-infected men -- a practice called "serosorting," where ...
Other Medicine News:Health News:FDA Advisors Declare 'FDA Science and Mission at Risk' 2Health News:Internists diagnose health-care system ills, show how to achieve universal coverage 2Health News:Internists diagnose health-care system ills, show how to achieve universal coverage 3Health News:Internists diagnose health-care system ills, show how to achieve universal coverage 4Health News:NCOA Commends Long Term Care Commission Report 2Health News:Consumer Reports 'Best Buy Drugs' Compares Best Medicines for Less 2Health News:Consumer Reports 'Best Buy Drugs' Compares Best Medicines for Less 3Health News:One-Third of HIV-Infected Gay Men Have Unsafe Sex: CDC 2Health News:One-Third of HIV-Infected Gay Men Have Unsafe Sex: CDC 3Health News:One-Third of HIV-Infected Gay Men Have Unsafe Sex: CDC 4
(Date:12/15/2009)... Calif., Dec. 15 Dakim, Inc. and Alzheimer,s ... for Loved Ones, Brain Health Contest, designed to help ... of dementia and Alzheimer,s disease. All five winners will ... designed specifically to help seniors preserve their brain health ... in senior living communities across the country. ...
(Date:12/15/2009)... --A Harvard medical expert internationally recognized as a ... Tour,s decision last month to suspend Doug Barron ... as having the medical condition hypogonadism ... "unreasonable, unfair and discriminatory." ,, Hypogonadism ... levels, often referred to informally as Low ...
(Date:12/15/2009)... Dec. 15 Today,s New ... "Plan for Kidney Drugs Spurs Division," illustrates an ... in kidney patients continuing to be deprived of ... Medicare program limit. ,, As Congress is poised ... preserve the lives of transplant kidney recipients, behind-the-scenes ...
Breaking Medicine Technology:5 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 25 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 3Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 2Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 3Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 4AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate 2Congressman Fattah Supports Legislation to Address More Funds for Pancreatic Cancer Research 60857 1Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th 14754 1Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th 14754 2Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th 14754 3Caraco Pharmaceutical Laboratories Ltd Markets Generic Acular 28R 29 Ophthalmic Solution 6058 1Caraco Pharmaceutical Laboratories Ltd Markets Generic Acular 28R 29 Ophthalmic Solution 6058 2
... and NYSE: SNY ) announced today that the ... in favor of the approval of Multaq(R) by the U.S. ... atrial fibrillation (AF). As demonstrated in the ATHENA trial, ... a clinical study a significant reduction in morbidity and mortality ...
... Alternext: ULU) announced that clinical evidence on ... the use of its patented Nanoflex(TM) Technology for Therapeutic ... Meeting in Los Angeles, California March 19-21. The ... on display during the meeting.Clinical evidence will be presented ...
Other Medicine Technology:FDA Advisory Committee Recommends Approval of Multaq(R) (dronedarone) 2FDA Advisory Committee Recommends Approval of Multaq(R) (dronedarone) 3ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009 2ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009 3
For the qualitative detection of IgG/IgM antibodies to B. burgdorferi...
... the finest surgical-quality loupes available ... standard for innovative optical design, combining ... Delivering optimum performance with maximum comfort, ... for medical professionals worldwide. All SheerVision ...
... Experience the finest surgical-quality loupes available ... the standard for innovative optical design, ... support. Delivering optimum performance with maximum ... choice for medical professionals worldwide. All ...
... the finest surgical-quality loupes available ... standard for innovative optical design, combining ... optimum performance with maximum comfort, SheerVision ... medical professionals worldwide. All SheerVision loupes ...
Medicine Products: